Maplight Therapeutics, Inc. · NASDAQ:MPLT
Lillie James Woodruff sold 22,082 Maplight Therapeutics, Inc. shares (Form 4)
Traded Aug 3, 2026 · Filed Aug 4, 2026
On Aug 3, 2026, Lillie James Woodruff (Chief Scientific Officer) sold 22,082 Maplight Therapeutics, Inc. shares at US$12.54 for US$277K under a trading plan, leaving 202,380 shares. Filed Aug 4, 2026 (Form 4).
- Sold
- 22,082 shares
- Price
- US$12.54
- Value
- US$277K
- Holding after
- 202,380 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Voting Common Stock | Sale | 22,082 | US$12.54 | 202,380 | Direct |
Source
Related
- Maplight Therapeutics, Inc.
- Lillie James Woodruff
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Lillie James Woodruff · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Aug 19, 2026
- Form 4 · Lillie James Woodruff · Jul 17, 2026
- Form 4 · Lillie James Woodruff · May 11, 2026
- Form 4 · Lillie James Woodruff · May 6, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026